Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Surgical management of neuroendocrine tumor-associated liver metastases: a review.

Literature DB >> 29629317

Surgical management of neuroendocrine tumor-associated liver metastases: a review.

Miu Yee Chan¹, Ka Wing Ma¹, Albert Chan¹.

Abstract

Liver metastasis is common among patients who suffer from neuroendocrine tumors (NETs). Radical surgery is the standard treatment whenever possible but there is still controversies concerning the treatment strategies such as resection of the primary, role of debulking surgery, liver transplantation (LT) and neoadjuvant or adjuvant therapies. This article aims to review the current evidence available, together with some latest updates, focusing on the surgical management.

Entities: Disease Species

Keywords: Neuroendocrine tumors/therapy; hepatectomy; liver neoplasms/secondary; liver neoplasms/surgery; liver transplantation (LT)

Year: 2018 PMID： 29629317 PMCID： PMC5876679 DOI： 10.21037/gs.2017.11.16

Source DB: PubMed Journal: Gland Surg ISSN： 2227-684X

65 in total

1. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?

Authors: Vincenzo Mazzaferro; Andrea Pulvirenti; Jorgelina Coppa
Journal: J Hepatol Date: 2007-07-26 Impact factor: 25.083

2. Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.

Authors: Xu-Feng Zhang; Eliza W Beal; Jeffery Chakedis; Yi Lv; Fabio Bagante; Luca Aldrighetti; George A Poultsides; Todd W Bauer; Ryan C Fields; Shishir Kumar Maithel; Hugo P Marques; Matthew Weiss; Timothy M Pawlik
Journal: J Gastrointest Surg Date: 2017-07-20 Impact factor: 3.452

3. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.

Authors: Julie Hallet; Calvin How Lim Law; Moises Cukier; Refik Saskin; Ning Liu; Simron Singh
Journal: Cancer Date: 2014-10-13 Impact factor: 6.860

4. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.

Authors: E Bertani; N Fazio; D Radice; C Zardini; G Spinoglio; A Chiappa; D Ribero; R Biffi; S Partelli; M Falconi
Journal: Eur J Surg Oncol Date: 2016-09-30 Impact factor: 4.424

Review 5. Therapeutic strategies for neuroendocrine liver metastases.

Authors: Andrea Frilling; Ashley K Clift
Journal: Cancer Date: 2014-10-01 Impact factor: 6.860

6. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.

Authors: Emilio Bertani; Massimo Falconi; Chiara Grana; Edoardo Botteri; Antonio Chiappa; Pasquale Misitano; Francesca Spada; Davide Ravizza; Barbara Bazolli; Nicola Fazio
Journal: Int J Surg Date: 2015-06-11 Impact factor: 6.071

Review 7. Epidemiology of Neuroendocrine Tumors.

Authors: Merav Fraenkel; Antongiulio Faggiano; Gerlof D Valk
Journal: Front Horm Res Date: 2015-08-14 Impact factor: 2.606

8. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

Authors: S T Fan; E C Lai; C M Lo; I O Ng; J Wong
Journal: Arch Surg Date: 1995-02

9. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.

Authors: D Citterio; S Pusceddu; A Facciorusso; J Coppa; M Milione; R Buzzoni; M Bongini; F deBraud; V Mazzaferro
Journal: Eur J Surg Oncol Date: 2016-11-24 Impact factor: 4.424